Building upon the success of 2018’s Interim Workshop on Cancer Immune Responsiveness (CIR), the goal of this year’s CIR workshop is the continued advancement of knowledge in the field about interactions between the immune system and cancer that contribute to immunotherapy response and resistance.Over this two-day workshop, participants will take part in both didactic sessions and working groups to identify and address key questions in the field concerning cancer immune responsiveness.Topics to be discussed include:
The Cancer Immune Responsiveness Task Force hosted a two-day workshop that brought together stakeholders to discuss topics including:
Access Program MaterialsEnduring materials from this program are available to the general public. Click here to access presentations to the program. Presentations and video recordings are available based on permission from presenters.
2018 Co-Chairs: Transcriptional Patterns of Distinct Immune LandscapesKwok-Kin Wong, MD, PhDNew York Langone HealthStephanie Spranger, PhDKoch Institute for Integrative Cancer Research at MIT
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report discussing two patients with relapsed ICC at stage IIIb were treated with PD-1 blockade combined with chemotherapy. These two ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article reporting an automated image analysis solution to determine the predictive and prognostic values of the product of PD-L1+ ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a short report suggesting that new vaccine formulations combined with local immunostimulation and standard-of-care chemotherapy have promise ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article in which Avelumab demonstrated safety and clinical activity in patients with laryngeal RRP. Authors: Clint T. Allen ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a short report evaluating the largest cohort of ICI-related HLH cases, and observing that ICI-related HLH arises with a delayed timing with ...
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com